Table 1 Clinical characteristics of the patients
Variable | n = 24 |
|---|---|
Age | 72.5 (54–88) |
Sex (female/male) | 6/18 |
Dose (8/12), mg | 8/16 |
BCLC staging (B/C) | 7/17 |
TNM staging (3/4a/4b) | 7/4/13 |
T (0/1/2/3/4) | 2/2/6/11/3 |
M (0/1) | 12/12 |
N (0/1) | 17/7 |
Main tumor size, mm | 30 (0–135) |
MVI (Vp2/Vp3/Vv) | 1/1/0 |
AFP, ng/mL | 10.3 (0.5–142,400) |
DCP, mAU/mL | 182.5 (13–37,535) |
ALBI grade(G1/G2) | 9/15 |
Platelet, ×10^4/μL | 15.7 (5.7–144) |
PT, % | 85.5 (68–110) |
Albumin, g/dL | 3.6 (2.9–4.8) |
Total bilirubin, mg/dL | 0.7 (0.4–1.7) |
AST, IU/L | 32 (16–163) |
ALT, IU/L | 20.5 (6–91) |
γGTP, IU/L | 50.5 (11–183) |
Etiology (HBV/HCV/NBNC) | 5/11/8 |